Key result
Intravenous l-NMMA and l-NAME drive dose-dependent hypertension and vasoconstriction in rats via NO-mediated tone.
In conscious rats, inhibition of NO synthesis with l-NMMA or l-NAME causes dose-dependent hypertension and regional vasoconstriction, highlighting substantial NO-mediated vasodilator tone in vivo.
Answers are grounded in this paper and cite their sources.
Establishes NO-mediated vasodilator tone in conscious rats; leaves open translation to human endothelial therapies.
Summary: Male, Long Evans and homozygous Brattleboro rats were chronically instrumented with pulsed Doppler probes (to monitor regional blood flows) or electromagnetic flow probes (to monitor cardiac output) and intravascular catheters. In conscious, unrestrained, Long Evans rats, hemodynamic responses to intravenous (i.v.) bolus doses of NG-monomethyl-l-arginine (l-NMMA, 0.3-300 mg/kg) and NG-nitro-l-arginine methyl ester (l-NAME, 0.1-10 mg/kg) were assessed. Both compounds produced dose-dependent hypertension, but the increase in mean arterial blood pressure was more rapid and the bradycardia more marked with l-NMMA than with l-NAME (although the latter did not affect cardiac baroreflex sensitivity). l-NMMA and l-NAME caused marked renal, mesenteric, and hindquarters vasoconstriction, particularly at the higher doses, but the profiles of change in vascular conductances following l-NMMA and l-NAME were different, possibly due to pharmacokinetic factors (l-NAME has to be converted to its active form by an esterase). l-arginine opposed the effects of l-NMMA and l-NAME. The hypertension induced by l-NAME was associated with marked reductions in cardiac index, stroke index, peak aortic flow (F), +dF/dtmax, and total peripheral conductance. These changes must have buffered the pressor effects of l-NAME, and could have been secondary to the increase in afterload. Brattleboro rats responded to i.v. l-NMMA and l-NAME in a similar way to Long Evans rats. Brattleboro rats provided with drinking water containing l-NMMA (1 mg/ml) or l-NAME (0.1 mg/ml) developed hypertension but no bradycardia; the hypertension was associated with a particularly marked hindquarters vasoconstriction. In Long Evans rates treated with l-NAME, the hypotensive responses to glyceryl trinitrate, acetylcholine, and endothelin-I were enhanced, and in some animals the hypotensive effect of bradykinin was also increased. In the presence of l-NAME, increases in regional blood flow still occurred in response to acetylcholine, bradykinin, and endothelin-l. Collectively, these results are consistent with a substantial, nitric oxide (NO)-mediated vasodilator tone in regional vascular beds in vivo. However, inhibition of this tone does not give a quantitative estimate of its importance because the pressor effect due to the fall in total peripheral conductance is opposed by a marked reduction in cardiac function. Under conditions in which NO-mediated vascular tone is substantially reduced, agonists such as acetylcholine, bradykinin, and endothelin-1 can still cause pronounced vasodilatations.
No takes yet. Share an insight, caveat, or question.
Gardiner et al. (1991) studied this question. NG-monomethyl-l-arginine (l-NMMA) and NG-nitro-l-arginine methyl ester (l-NAME) was evaluated on Hemodynamic responses (blood pressure, heart rate, regional blood flows). Intravenous l-NMMA and l-NAME produced dose-dependent hypertension and marked regional vasoconstriction in conscious rats, consistent with substantial NO-mediated vasodilator tone.
Synapse has enriched 10 related papers. Consider them for comparative context: